|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Account receivable – related party | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| NONCURRENT ASSETS: | ||||||||||||||||||||
| Fixed assets | ||||||||||||||||||||
| Other receivables -Income From HFT | ||||||||||||||||||||
| Other interest receivables | ||||||||||||||||||||
| Other receivables -SUIC Beneway USA Inc. | ||||||||||||||||||||
| Other interest receivables | ||||||||||||||||||||
| Other loans receivables | ||||||||||||||||||||
| Investment in equities | ||||||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Credit card payable | ||||||||||||||||||||
| Loans payables- others | ||||||||||||||||||||
| Other payables - related party | ||||||||||||||||||||
| Short term debts | ||||||||||||||||||||
| Accrued salary payable | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other payables - related party | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Convertible promissory notes- other | ||||||||||||||||||||
| NON-CURRENT LIABILITIES: | ||||||||||||||||||||
| Convertible promissory notes- other | ||||||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Deficiency | ||||||||||||||||||||
| Common stock, $0.001 par value, 394,500,000 shares authorized; 50,646,938 shares and 11,396,638 shares issued and outstanding on June 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Deficiency | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficiency | ||||||||||||||||||||
Loading...
